Monday, September 28, 2020
   
Text Size

Site Search

11/11/07 - NanoVir Scientific Director Speaks at Beijing Conference

Nov. 11, 2007
KALAMAZOO, Mich. - Dr. Chris Fisher, co-founder of NanoVir, LLC and the company's Director of Biology, has been invited to speak on November 4, 2007 at the 24th International Papillomavirus Conference and Clinical Workshop in Beijing, China. The Workshop will run November 3-9, 2007.

As part of a talk focusing on the treatment of human papillomavirus (HPV), cervical intraepithelial neoplasia and cervical cancer, Dr. Fisher will give an invited lecture on the state of the art in viral chemotherapy for HPV.

"To have NanoVir's research represented at such a prestigious event is an honor. I am delighted to have been selected to speak," said Dr. Fisher. "The contacts and relationships made at this event will undoubtedly further our knowledge and increase our network - for the future."

The conference, organized jointly by the International Papillomavirus Society and the Chinese Medical Association, is the second meeting of its kind to be held in Asia since 1984. The scientific sessions will be formally held at the internationally acclaimed Beijing International Convention Center, located near such popular tourist attractions as the Forbidden City and the Great Wall.

NanoVir, LLC is a Michigan-based company whose headquarters are located at the Southwest Michigan Innovation Center in Kalamazoo, Michigan. NanoVir is working on prevention of cervical cancer by developing antiviral agents for HPV, the cause of the vast majority of cervical cancer. The company is funded by the National Institutes of Health, under the National Institute of Allergies and Infectious Diseases.

About the International Papillomavirus Society

The International Papillomavirus Society facilitates research on human and animal papillomaviruses and their associated diseases and promotes the translation of research results into new clinical applications and public health policies. The Society serves as the organizational structure for the field of biomedical scientists and physicians engaged in all manner of papillomavirus research. It also promotes translational research involving basic and clinical scientists as well as epidemiologists and public health workers at academic, governmental and corporate laboratories and hospitals. More information about the Society can be found at www.ipvsoc.com.